Comparative study of apamarga kshartaila versus eusol as desloughing agent w.s.r. to shodhankarma in the management of dushtavrana. A randomised controlled trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- This study may provide use of Apamarga Kshar Taila
研究概览
简要总结
This study will be carried out at opd of Shalyatantra department of Pakwasa Samnvay Rugnalaya ,Nagpur .This is an open label randomized controlled trial aims at studying the comparison between desloughing effect of Apamarga Kshar Taila and eusol in dushtavrana patients.Total 36 patients will be included and will be randomly divided into two groups i.e. Group A and Group B each containing 18 patients.Group A will be trial group where patients will receive application of Apamarga Kshar Taila and Group B will be control group will receive application of eusol.Then patients will be observed on 7th,14th and 21st day.All the findings will be recorded in case record form.At the end of trial, collected data will be analyzed and result will be drawn accordingly.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients from the age group 18-70 years irrespective of gender, religion, occupation, and socio-economic status.
- •Patients diagnosed with Dushtavrana.
- •Wound length upto 10 cm and width upto 10cm 4)Wound without any major complications 5)Wound present more than 4 weeks.
排除标准
- •Patients suffering from Malignant ulcers, Syphilitic ulcers , Lepromatous ulcer ,diabetic wound and Tubercular ulcers will be excluded from the study.
- •Patients having history of bleeding disorders and anaemia having haemoglobin % less than 6 gm 3)Immuno -compromised patients like syphilis, HIV, HBsAg positive.
结局指标
主要结局
This study may provide use of Apamarga Kshar Taila
时间窗: At the end of 21 days
as conservative treatment option for
时间窗: At the end of 21 days
Dushtavrana.
时间窗: At the end of 21 days
次要结局
- Comparative effect of desloughing between apamarga kshartaila and eusol in dushtavrana will be assessed(At the end of 21 days)
研究者
Dr Vaishnavi Baburao Charhate
Shri Ayurved Mahavidyala,Nagpur